한글목차

세계의 ECG 장비 시장 규모는 2023-2032년 예측기간 중 5.52%의 CAGR로 확대될 것으로 예측됩니다. 세계 시장 성장에 기여하는 시장 성장 촉진요인으로는 심혈관질환의 높은 유병률, 고령자 인구 증가에 의한 모니터링 기기 사용 증가, 헬스케어 지출 증가 등을 들 수 있습니다

세계의 ECG 장비 시장에 대해 조사했으며, 시장 개요와 함께 리드 유형별, 제품별, 시스템별, 최종사용자별, 지역별 동향, 경쟁 상황 및 시장에 참여하는 기업 개요 등을 제공합니다.

목차

제1장 조사 범위와 조사 방법

제2장 주요 요약

제3장 시장 역학

• 주요 성장 촉진요인
• 주요 성장 억제요인

제4장 주요 분석

• 주요 시장 동향
• Porter's Five Forces 분석
• 시장 성숙도 분석
• 밸류체인 분석
• 주요 구입 기준
• 규제 체계

제5장 리드 유형별 시장

• 싱글 리드
• 3-6 리드
• 12 리드

제6장 제품별 시장

• 진단용 심전도 시스템
• ECG 모니터링 시스템

제7장 시스템별 시장

• 정지형 심전도 시스템
• 휴대용 심전도 시스템

제8장 최종사용자별 시장

• 병원과 진료소
• 재택/외래 진료
• 기타

제9장 지역별 분석

• 북미
• 유럽
• 아시아태평양
• 기타 지역

제10장 경쟁 상황

• 주요 전략적 전개
• 기업 개요
  • BIONET CO LTD
  • BIOTELEMETRY INC
  • COMPUMED INC
  • GE HEALTHCARE
  • HILL-ROM HOLDINGS INC
  • MCKESSON CORPORATION
  • MINDRAY MEDICAL INTERNATIONAL LIMITED
  • NIHON KOHDEN CORPORATION
  • PHILIPS HEALTHCARE
  • SCHILLER AG
  • SIEMENS HEALTHINEERS AG
  • SPACELABS HEALTHCARE
  • WELCH ALLYN INC(ACQUIRED BY HILL-ROM)
  • ZOLL MEDICAL CORPORATION

영문목차

KEY FINDINGS

The global ECG equipment market is projected to register a CAGR of 5.52% during the forecast period, 2023 to 2032. Some of the top drivers contributing to the global market's growth include the high prevalence of cardiovascular diseases, the increasing usage of monitoring devices due to the rising geriatric population, as well as the growing healthcare spending.

MARKET INSIGHTS

ECG is used to measure the electrical activities of the heart. The electrical impulses generated by the heart are recorded using electrodes and then translated into a waveform. Given the shifting lifestyles, there has been an increase in cardiovascular diseases globally. Also, heart diseases are the leading cause of death in the United States, as per the Centers for Disease Control and Prevention data. In addition, around 647,000 Americans die due to heart disease every year.

Further, the World Health Organization (WHO) predicts that 23.3 million people will be affected by CVD and CHD by 2030. Also, statistics suggest that CVDs result in 1.8 million deaths in the European Union (EU) as well as 3.9 million deaths in Europe. Cardiovascular ailments are also projected to be the prominent cause of all mortalities. Hence, the high prevalence of heart diseases has increased the demand for ECG equipment, thereby propelling the global ECG equipment market growth during the forecast period. However, intense competition among vendors, coupled with complex reimbursement policies regarding cardiovascular diseases (CVD), may likely hinder the market's growth.

REGIONAL INSIGHTS

The global ECG equipment market growth assessment includes the geographical analysis of Asia-Pacific, Europe, North America, and Rest of World. Asia-Pacific is set to be the fastest-growing region during the forecast period. The market's notable growth is fuelled by factors such as a robust medical device manufacturing base, the presence of an extensive network of electronic as well as semiconductor equipment, and the high prevalence of cardiac disorders.

COMPETITIVE INSIGHTS

As remote cardiac activity monitoring becomes highly pronounced during the forecast period, the competition is anticipated to be high among players operating in the global ECG equipment market. Some of the leading companies in the market include Philips Healthcare, Schiller AG, Siemens Healthineers AG, etc.

Our report offerings include:

• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation caters to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• The competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

• 1.1. STUDY OBJECTIVES
• 1.2. METHODOLOGY
• 1.3. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

• 2.1. MARKET SIZE & ESTIMATES
• 2.2. MARKET OVERVIEW
• 2.3. SCOPE OF STUDY
• 2.4. CRISIS SCENARIO ANALYSIS

3. MARKET DYNAMICS

• 3.1. KEY DRIVERS
  • 3.1.1. PREVALENCE OF CARDIOVASCULAR DISEASES
  • 3.1.2. INCREASING USAGE OF MONITORING DEVICES DUE TO RISING GERIATRIC POPULATION
  • 3.1.3. GROWING HEALTHCARE SPENDING
• 3.2. KEY RESTRAINTS
  • 3.2.1. INTENSE COMPETITION AMONG VENDORS
  • 3.2.2. COMPLEX REIMBURSEMENT POLICIES REGARDING CARDIOVASCULAR DISEASES (CVD)

4. KEY ANALYTICS

• 4.1. KEY MARKET TRENDS
• 4.2. PORTER'S FIVE FORCES ANALYSIS
  • 4.2.1. BUYERS POWER
  • 4.2.2. SUPPLIERS POWER
  • 4.2.3. SUBSTITUTION
  • 4.2.4. NEW ENTRANTS
  • 4.2.5. INDUSTRY RIVALRY
• 4.3. MARKET MATURITY ANALYSIS
• 4.4. VALUE CHAIN ANALYSIS
• 4.5. KEY BUYING CRITERIA
• 4.6. REGULATORY FRAMEWORK

5. MARKET BY LEAD TYPE

• 5.1. SINGLE LEAD
• 5.2. 3-6 LEAD
• 5.3. 12-LEAD

6. MARKET BY PRODUCT

• 6.1. DIAGNOSTIC ECG SYSTEM
  • 6.1.1. REST ECG SYSTEM
  • 6.1.2. STRESS ECG SYSTEM
  • 6.1.3. HOLTER ECG SYSTEM
• 6.2. MONITORING ECG SYSTEM
  • 6.2.1. EVENT MONITORING
  • 6.2.2. CONTINUOUS MONITORING
  • 6.2.3. REMOTE MONITORING

7. MARKET BY SYSTEM

• 7.1. STATIONARY ECG SYSTEM
• 7.2. PORTABLE ECG SYSTEM
  • 7.2.1. APPLICATIONS OF PORTABLE ECG SYSTEMS IN DIGITAL AND TELEHEALTH MARKET
    • 7.2.1.1. CASE STUDY- 1: DEVELOPMENT OF PORTABLE ECG DEVICES
    • 7.2.1.2. CASE STUDY- 2: TELECARDIOLOGY
    • 7.2.1.3. CASE STUDY- 3: USE OF WEARABLE DEVICES FOR AMBULATORY MONITORING
  • 7.2.2. HANDHELD ECG SYSTEM
  • 7.2.3. WEARABLE ECG SYSTEM
  • 7.2.4. PEN ECG SYSTEM
  • 7.2.5. OTHER PORTABLE ECG SYSTEMS

8. MARKET BY END-USER

• 8.1. HOSPITALS & CLINICS
• 8.2. HOME/AMBULATORY CARE
• 8.3. OTHER END-USERS

9. GEOGRAPHICAL ANALYSIS

• 9.1. NORTH AMERICA
  • 9.1.1. MARKET SIZE & ESTIMATES
  • 9.1.2. NORTH AMERICA ECG EQUIPMENT MARKET DRIVERS
  • 9.1.3. NORTH AMERICA ECG EQUIPMENT MARKET CHALLENGES
  • 9.1.4. KEY PLAYERS IN NORTH AMERICA ECG EQUIPMENT MARKET
  • 9.1.5. COUNTRY ANALYSIS
    • 9.1.5.1. UNITED STATES
    • 9.1.5.1.1. UNITED STATES ECG EQUIPMENT MARKET SIZE & OPPORTUNITIES
    • 9.1.5.2. CANADA
    • 9.1.5.2.1. CANADA ECG EQUIPMENT MARKET SIZE & OPPORTUNITIES
• 9.2. EUROPE
  • 9.2.1. MARKET SIZE & ESTIMATES
  • 9.2.2. EUROPE ECG EQUIPMENT MARKET DRIVERS
  • 9.2.3. EUROPE ECG EQUIPMENT MARKET CHALLENGES
  • 9.2.4. KEY PLAYERS IN EUROPE ECG EQUIPMENT MARKET
  • 9.2.5. COUNTRY ANALYSIS
    • 9.2.5.1. UNITED KINGDOM
    • 9.2.5.1.1. UNITED KINGDOM ECG EQUIPMENT MARKET SIZE & OPPORTUNITIES
    • 9.2.5.2. GERMANY
    • 9.2.5.2.1. GERMANY ECG EQUIPMENT MARKET SIZE & OPPORTUNITIES
    • 9.2.5.3. FRANCE
    • 9.2.5.3.1. FRANCE ECG EQUIPMENT MARKET SIZE & OPPORTUNITIES
    • 9.2.5.4. ITALY
    • 9.2.5.4.1. ITALY ECG EQUIPMENT MARKET SIZE & OPPORTUNITIES
    • 9.2.5.5. SPAIN
    • 9.2.5.5.1. SPAIN ECG EQUIPMENT MARKET SIZE & OPPORTUNITIES
    • 9.2.5.6. BELGIUM
    • 9.2.5.6.1. BELGIUM ECG EQUIPMENT MARKET SIZE & OPPORTUNITIES
    • 9.2.5.7. POLAND
    • 9.2.5.7.1. POLAND ECG EQUIPMENT MARKET SIZE & OPPORTUNITIES
    • 9.2.5.8. REST OF EUROPE
    • 9.2.5.8.1. REST OF EUROPE ECG EQUIPMENT MARKET SIZE & OPPORTUNITIES
• 9.3. ASIA-PACIFIC
  • 9.3.1. MARKET SIZE & ESTIMATES
  • 9.3.2. ASIA-PACIFIC ECG EQUIPMENT MARKET DRIVERS
  • 9.3.3. ASIA-PACIFIC ECG EQUIPMENT MARKET CHALLENGES
  • 9.3.4. KEY PLAYERS IN ASIA-PACIFIC ECG EQUIPMENT MARKET
  • 9.3.5. COUNTRY ANALYSIS
    • 9.3.5.1. CHINA
    • 9.3.5.1.1. CHINA ECG EQUIPMENT MARKET SIZE & OPPORTUNITIES
    • 9.3.5.2. JAPAN
    • 9.3.5.2.1. JAPAN ECG EQUIPMENT MARKET SIZE & OPPORTUNITIES
    • 9.3.5.3. INDIA
    • 9.3.5.3.1. INDIA ECG EQUIPMENT MARKET SIZE & OPPORTUNITIES
    • 9.3.5.4. SOUTH KOREA
    • 9.3.5.4.1. SOUTH KOREA ECG EQUIPMENT MARKET SIZE & OPPORTUNITIES
    • 9.3.5.5. THAILAND
    • 9.3.5.5.1. THAILAND ECG EQUIPMENT MARKET SIZE & OPPORTUNITIES
    • 9.3.5.6. INDONESIA
    • 9.3.5.6.1. INDONESIA ECG EQUIPMENT MARKET SIZE & OPPORTUNITIES
    • 9.3.5.7. VIETNAM
    • 9.3.5.7.1. VIETNAM ECG EQUIPMENT MARKET SIZE & OPPORTUNITIES
    • 9.3.5.8. AUSTRALIA & NEW ZEALAND
    • 9.3.5.8.1. AUSTRALIA & NEW ZEALAND ECG EQUIPMENT MARKET SIZE & OPPORTUNITIES
    • 9.3.5.9. REST OF ASIA-PACIFIC
    • 9.3.5.9.1. REST OF ASIA-PACIFIC ECG EQUIPMENT MARKET SIZE & OPPORTUNITIES
• 9.4. REST OF WORLD
  • 9.4.1. MARKET SIZE & ESTIMATES
  • 9.4.2. REST OF WORLD ECG EQUIPMENT MARKET DRIVERS
  • 9.4.3. REST OF WORLD ECG EQUIPMENT MARKET CHALLENGES
  • 9.4.4. KEY PLAYERS IN REST OF WORLD ECG EQUIPMENT MARKET
  • 9.4.5. REGIONAL ANALYSIS
    • 9.4.5.1. LATIN AMERICA
    • 9.4.5.1.1. LATIN AMERICA ECG EQUIPMENT MARKET SIZE & OPPORTUNITIES
    • 9.4.5.2. MIDDLE EAST & AFRICA
    • 9.4.5.2.1. MIDDLE EAST & AFRICA ECG EQUIPMENT MARKET SIZE & OPPORTUNITIES

10. COMPETITIVE LANDSCAPE

• 10.1. KEY STRATEGIC DEVELOPMENTS
  • 10.1.1. MERGERS & ACQUISITIONS
  • 10.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
  • 10.1.3. PARTNERSHIPS & AGREEMENTS
  • 10.1.4. BUSINESS EXPANSIONS & DIVESTITURES
• 10.2. COMPANY PROFILES
  • 10.2.1. BIONET CO LTD
  • 10.2.2. BIOTELEMETRY INC
  • 10.2.3. COMPUMED INC
  • 10.2.4. GE HEALTHCARE
  • 10.2.5. HILL-ROM HOLDINGS INC
  • 10.2.6. MCKESSON CORPORATION
  • 10.2.7. MINDRAY MEDICAL INTERNATIONAL LIMITED
  • 10.2.8. NIHON KOHDEN CORPORATION
  • 10.2.9. PHILIPS HEALTHCARE
  • 10.2.10. SCHILLER AG
  • 10.2.11. SIEMENS HEALTHINEERS AG
  • 10.2.12. SPACELABS HEALTHCARE (SUBSIDIARY OF OSI SYSTEMS INC)
  • 10.2.13. WELCH ALLYN INC (ACQUIRED BY HILL-ROM)
  • 10.2.14. ZOLL MEDICAL CORPORATION (ACQUIRED BY ASAHI KASEI)